AOTI Share Price Performance
UK£0.60
-0.25 (-29.41%)
18.9% undervalued intrinsic discount
UK£0.74
Fair Value
Price UK£0.60
AnalystConsensusTarget UK£0.74
Fair ValueUK£0.74
Share Pricen/a
AOTI, Inc. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
AOTI Community Narratives
AN
Fair Value
·Fair Value UK£0.74 18.9% undervalued intrinsic discount
Broader CMS Coverage And Home Care Trends Will Reshape This Chronic Wound Therapy Business
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Broader CMS Coverage And Home Care Trends Will Reshape This Chronic Wound Therapy Business
Catalysts About AOTI AOTI provides topical wound oxygen therapy and at home care services aimed at healing hard to heal chronic wounds. What are the underlying business or industry changes driving this perspective?Read more
AN
UK£0.74
18.9% undervalued intrinsic discount
Fair Value
Revenue
14.79% p.a.
Profit Margin
22.49%
Future PE
5.87x
Price in 2029
UK£0.94
Trending Discussion
Recently Updated Narratives
AN
Broader CMS Coverage And Home Care Trends Will Reshape This Chronic Wound Therapy Business
Fair Value: UK£0.74 18.9% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
AOTI, Inc. Key Details
About AOTI
- Founded
- 2008
- Employees
- 94
- CEO
- WebsiteView website
AOTI, Inc., together with its subsidiaries, produces, rents, and sells medical devices to resolve severe acute and chronic wounds for customers worldwide. The company offers topical wound oxygen solutions for use in the institutional and the home care settings to improve the health, well-being, and independence of patients; and NEXA, an negative pressure wound therapy system. AOTI, Inc. was incorporated in 2008 and is based in Oceanside, California.
